EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy

Yu Cao iD, Gaoya Xu, Lixin Gao, Jingjing Sun, Lu Zhang, Qiao Tong, Limin Kong, Jiankang Zhang, Yubo Zhou, Li Liao, Liping Fu, Jianjun Xi iD

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Yu Cao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Preparation, Hangzhou Xixi Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Proteasome Inhibitors, Antineoplastic Agents, beta-Lactams. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the Construction Fund of Key Medical Disciplines of Hangzhou (2025HZZD13), the Zhejiang Provincial Natural Science Foundation of China….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of dipeptidic proteasome inhibitors with β ‐lactam as the C ‐terminus was designed and synthesized. Biochemical evaluations of their effects on chymotrypsin‐like (CT‐L) activity revealed that some of them had inhibitory activity against the proteasome, with IC 50 values in the micromolar range. Based on the enzymatic results, structure–activity relationships (SAR) were discussed in detail. Some potent compounds were further selected for antiproliferative assays toward multiple cancer cell lines, with compounds 66 and 78 demonstrating activity against RS4;11 cells and IC 50 values of less than 1 μM. Additionally, cellular mechanistic studies indicated that these effects were linked to their ability to inhibit proteasome signal pathways and to induce apoptosis in RS4;11 cells, as demonstrated by flow cytometry. Collectively, these results illustrate that compound 66 is a potent proteasome inhibitor with significant potential as an antitumor agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome InhibitorsAntineoplastic Agentsbeta-LactamsStructure-Activity RelationshipHumansCell ProliferationCell Line, TumorApoptosisDrug Screening Assays, AntitumorMolecular StructureDose-Response Relationship, DrugProteasome Endopeptidase Complex

Stichwörter der Autor:innen

antitumorproteasome inhibitorsstructure–activity relationshipsβ‐lactam

Substanzen

Proteasome InhibitorsAntineoplastic Agentsbeta-LactamsProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Pharmaceutical Preparation, Hangzhou Xixi Hospital, Hangzhou, China.
  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Department of Clinical Pharmacy, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China.
  • Department of Pharmacy, Hangzhou Children's Hospital, Hangzhou, China.

ORCID-Profile: Yu Cao, Jianjun Xi

Förderung

  • This study was funded by the Construction Fund of Key Medical Disciplines of Hangzhou (2025HZZD13), the Zhejiang Provincial Natural Science Foundation of China…

Zitieren

APA

Cao, Y., Xu, G., Gao, L., Sun, J., Zhang, L., Tong, Q., Kong, L., Zhang, J., Zhou, Y., Liao, L., Fu, L., & Xi, J. (2025). Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70136

Vancouver

Cao Y, Xu G, Gao L, Sun J, Zhang L, Tong Q, et al. Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70136

BibTeX
@article{Cao2025,
  author = {Cao, Yu and Xu, Gaoya and Gao, Lixin and Sun, Jingjing and Zhang, Lu and Tong, Qiao and Kong, Limin and Zhang, Jiankang and Zhou, Yubo and Liao, Li and Fu, Liping and Xi, Jianjun},
  title = {Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70136}
}
Kostenlos starten →